Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2342)	6/11/2010 1:32:14 PM
From: Jibacoa	Respond to of 3722

After apparently it found suport at the $15 level, AMLN is bouncing up for 2nd day on a roll.<g> The stock is off from its intraday H of $16.97 as it is having some downticks as I am writing, but it is still up 7.54% on volume of 1.685M about 0.4x its ADV The stock is trying to get above the resistance at the $17 level.<g> bigcharts.marketwatch.com AMLN's CEO will be presenting at the GS 31st Annual Global Healthcare Conference in L.A. on June 16. AMLN has been able to trim some its losses in the last 4Qs in spite of lower revenues. The ACTAY is $23.08 But if the stock can close above $17 it still has resistance at $18.20 & more importantly at the $20 level, before reaching that goal.<g> bigcharts.marketwatch.com Bernard